Skip to main content

Genomics of Emerging Viral Diseases

Guest Editors: 

Victoria Pando-Robles: Center of Research in Infectious Diseases in the National Public Health Institute of Mexico, Mexico

Claudia Sanchez San Martin: Division of Infectious Diseases and Vaccinology, School of Public Health, UC Berkeley, USA

BMC Genomics welcomed submissions to our Collection on Genomics of Emerging Viral Diseases. In the first two decades of the XXI century, the emergence of a new viral diseases such as COVID-19, Zika and Influenza H1N1 (among others) has demonstrated the vulnerability of public and animal health as well as that of the economy and stability of modern society worldwide. Zoonosis has played a notable role in the emergence of novel diseases; it is known that 70% of new etiological pathogens (principally bacterial and viral ones) have jumped from animals to humans before disseminating into the world.

Meet the Guest Editors

Back to top

Victoria Pando-Robles: Center of Research in Infectious Diseases in the National Public Health Institute of Mexico, Mexico

Victoria Pando-Robles is an associate professor at the Center of Research in Infectious Diseases in the National Public Health Institute of Mexico. She studied Chemistry at the Cayetano Heredia Peruvian University and obtained her Ph.D. in Science from the National Autonomous University of Mexico (UNAM) in 2002. Her research is focused on understanding cell host and dengue virus interactions, using a proteomics and biological systems approach. Also, her interest is to explain the reasons for their emergence and different patterns of dispersal, focusing particularly on the mosquito vectors which are important determinants of arbovirus emergence. Dr. Pando is a member of the editorial board of BMC Genomics and a founding member of the Mexican Proteomics Society.


Claudia Sanchez San Martin: University of California, Department of Laboratory Medicine, USA

Claudia Sanchez San Martin is a Scientist at UC Berkeley. Her research interests have been focused on infectious diseases, virology and bacteriology. She has extensive experience in the development and use of biological models to address questions related to pathogenesis, viral protein-protein interactions, drug discovery and transcriptomics. Her work has been dedicated on the understanding of the infection mechanisms of different microbiological systems, such as alphaviruses, flaviviruses, rotavirus and enteropathogenic E. coli as well as the search for drugs that can inhibit viral protein-protein interactions and infection using high-throughput techniques. With Dr. Chiu at UCSF, her research focused on characterization of emerging viruses, such as the human pegivirus 2 (HPgV-2), enterovirus D68 (EV-D68), and Zika virus (ZIKV) and COVID-19. Currently, at Dr. Eva Harris laboratory at UCB, she is an assistant project scientist, where in addition to contributing to understand the role of the dengue NS1 protein in infection, she oversees projects, personnel and grants.

BMC Genomics is calling for submissions to our Collection on Genomics of Emerging Viral Diseases. 

In the first two decades of the XXI century, the emergence of a new viral diseases such as COVID-19, Zika and Influenza H1N1 (among others) has demonstrated the vulnerability of public and animal health as well as that of the economy and stability of modern society worldwide. Zoonosis has played a notable role in the emergence of novel diseases; it is known that 70% of new etiological pathogens (principally bacterial and viral ones) have jumped from animals to humans before disseminating into the world.

Currently, the genomic approach is used in virology research to perform genomic characterization, study host response and for surveillance of emerging viral pathogens.  Future epidemiology and virology investigations will use genomics in combination with a variety of clinical, experimental, and bioinformatics approaches to facilitate a more comprehensive understanding of emergent viruses and the host response to these viruses.

This Guest Edited Collection in BMC Genomics welcomes submissions focused on genomic perspectives on the evolution and spread of emerging viruses, molecular basis of the host response (transcriptomic, proteomics, metabolomics), computational models on virus-disease association predictions, molecular characterization of emerging viruses and zoonotic viruses with potential emergence.


 Image credit: © sdecoret / stock.adobe.com

  1. Central Michigan University (CMU) participated in a state-wide SARS-CoV-2 wastewater monitoring program since 2021. Wastewater samples were collected from on-campus sites and nine off-campus wastewater treatme...

    Authors: Michael J. Conway, Hannah Yang, Lauren A. Revord, Michael P. Novay, Rachel J. Lee, Avery S. Ward, Jackson D. Abel, Maggie R. Williams, Rebecca L. Uzarski and Elizabeth W. Alm
    Citation: BMC Genomics 2024 25:59
    Content type: Research Published on:

  2. Bats are renowned for harboring a high viral diversity, their characteristics contribute to emerging infectious diseases. However, environmental and anthropic factors also play a significant role in the emerge...

    Authors: Nádia K. Albuquerque, Sandro P. Silva, Carine F. Aragão, Tânia Cristina A. S. Cunha, Francisco A. S. Paiva, Taciana F. S. B. Coelho and Ana Cecília R. Cruz
    Citation: BMC Genomics 2024 25:34
    Content type: Research Published on:

  3. Non-coding RNAs (ncRNAs) draw much attention from studies widely in recent years because they play vital roles in life activities. As a good complement to wet experiment methods, computational prediction metho...

    Authors: Ning Ai, Yong Liang, Haoliang Yuan, Dong Ouyang, Shengli Xie and Xiaoying Liu
    Citation: BMC Genomics 2023 24:424
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, SNAPP. During the submission process you will be asked whether you are submitting to a Collection, please select "Genomics of emerging viral diseases" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.